Author

M. Dwidar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

N. Sangwan· 2 shared A. Hajjar· 1 shared A. S. Joehlin-Price· 1 shared A. Santos· 1 shared A.-M. C. Overstreet· 1 shared B. Anderson· 1 shared B. Michaud· 1 shared C. Braley· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

N. Sangwan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HMGB1 acts as an agent of host defense at the gut mucosal barrier

A.-M. C. Overstreet, B. Anderson, M. Burge, X. Zhu, Y. Tao, C. Cham, B. Michaud, S. Horam, N. Sangwan, M. Dwidar, X. Liu, A. Santos, C. Finney, Z. Dai, V. Leone, J. S. Messer

This study identifies HMGB1 as a host defense molecule in the gut mucosal barrier that targets bacterial adhesins to prevent microbial invasion and adhesion.

bioRxiv · May 30, 2023 · PreprintMicrobiology

Disruption of the gut microbiota attenuates epithelial ovarian cancer sensitivity to cisplatin therapy

L. Chambers, E. L. Esakov, C. Braley, L. Trestan, Z. Alali, D. Bayik, J. Lathia, N. Sangwan, P. Bazeley, A. S. Joehlin-Price, M. Dwidar, A. Hajjar, P. P. Ahern, J. Claesen, P. Rose, , O. Reizes

This study shows that antibiotic treatment disrupts the gut microbiome, leading to increased resistance to cisplatin in ovarian cancer models.

bioRxiv · Jun 16, 2020 · PreprintCancer Biology